- Global Pharma News & Resources

[PDF] Sucralfate Market Potential Revenue Opportunities To Be Extremely Strong

Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes and helps ulcers to heal more quickly. Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat, which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease.

To prevent any significant side effects of sucralfate and to meet the important unmet needs of patients, key market players and government authorities are focusing on updating product details and raising awareness. For example, the US Food and Drug Administration approved a change in the labelling details for Teva Pharmaceutical Industries, Ltd. and Mylan, Inc.’s product Carafate in August 2017. The manufacturer revised the alert and precaution section of the labelling to include the possibility of pulmonary and cerebral emboli caused by the improper administration of Carafate intravenously.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @

Furthermore, the growth of the sucralfate market in the United States is expected to be fueled by a growing number of prescriptions for various indications each year. According to the Medical Expenditure Panel Survey (MEPS) study from 2019, 2 million sucralfate prescriptions were written in the United States in 2016 for a variety of indications including stomach ulcers, gastro-esophageal reflux disorder, and others.

Furthermore, the growing geriatric population in the United States, as well as the incidences of gastric diseases among the elderly, is expected to drive market growth over the forecast period. According to a 2016 study on ‘Aging in the United States,’ the number of Americans aged 65 and older is expected to double from 46 million in 2016 to over 98 million by 2060, according to the report.

Segmentation Analysis:

By Formulation:

  • Tablet
  • Liquid Suspension
    • Unit Dose Cup
    • Bottle

By Indication:

  • Gastric Ulcers
  • Duodenal Ulcers
  • Gastro Esophageal Reflux Disease (GERD)
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

If opting for the Global version of U.S. Sucralfate Market analysis is provided for major regions as follows:

North America (The US, Canada, and Mexico)

Europe (the UK, Germany, France, and Rest of Europe)

Asia Pacific (China, India, and Rest of Asia Pacific)

Latin America (Brazil and Rest of Latin America)

Middle East & Africa (Saudi Arabia, the UAE, South Africa, and Rest of Middle East & Africa)

Key Players

Major players operating in the U.S. sucralfate market include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc.

Buy This Complete A Business Report With Flat US $2000 Off @

Key Takeaways:

Because of the raising occurrence of duodenal ulcers and peptic ulcers in the United States, the sucralfate market in the United States is projected to grow at a CAGR of 3.1 percent over the forecast period. According to a 2018 report by the American Association for the Study of Liver Diseases, peptic ulcer disease (PUD) affects about 4.5 million people in the United States each year.

Due to the recommendation of tablet in different forms of gastric ulcers, the tablet segment held a dominant role in the U.S. sucralfate market in 2018. Sucralfate tablets, for example, are used to treat duodenal and non-malignant gastric ulcers. They’re also used to prevent recurrence of duodenal ulcers.

Because of the growing number of retail or independent pharmacies, the retail pharmacies segment retained a dominant position in the US sucralfate market in 2018. According to the PLOS Journal, the number of independent pharmacies in the United States increased by 3.8 percent from 22,737 in 2007 to 23,596 in August 2017. (2015).

Table of Content

Global U.S. Sucralfate Market Research Report

Section 1: Global U.S. Sucralfate Industry Overview

Section 2: Global Economic Impact on U.S. Sucralfate Industry

Section 3: Global Market Competition by Industry Producers

Section 4: Global Productions, Revenue (Value), according to Regions

Section 5: Global Supplies (Production), Consumption, Export, Import, geographically

Section 6: Global Productions, Revenue (Value), Price Trend, Product Type

Section 7: Global Market Analysis, on the basis of Application

Section 8: U.S. Sucralfate Market Pricing Analysis

Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers

Ask Analyst for Customization and Explore full report with TOC & List of Figures:

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 14-Sep-2021